KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
102 hedge funds and large institutions have $138M invested in Chinook Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 20 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 85 → 102 (+17)
Holders
102
Holding in Top 10
–
Calls
$274K
Puts
$3K
Top Buyers
| 1 | +$7.72M | |
| 2 | +$3.16M | |
| 3 | +$2.35M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.18M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$2.05M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$6.69M | |
| 3 | -$3.22M | |
| 4 |
BlackRock
New York
|
-$1.27M |
| 5 |
Morgan Stanley
New York
|
-$1.02M |